Treatment with captopril abrogates the altered expression of alpha1 macroglobulin and alpha1 antiproteinase in sera of spontaneously hypertensive rats

Proteome Science

Onn H Hashim³  See Z Hoe¹  Ruby Husain¹  Saiful A Karsani⁴  Hasni Misbah³  Nur-Atiqah H Abdullah²  Norhaniza Aminudin⁴ 

[1] Department of Physiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia;Institute of Biological Sciences, Faculty of Science, University of Malaya, 50603 Kuala Lumpur, Malaysia;Department of Molecular Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia;University of Malaya Centre for Proteomics Research, University of Malaya, Kuala Lumpur, Malaysia

关键词: proteomics;    serum proteins;    spontaneously hypertensive rats;    biomarker;    hypertension;   

Others  :  817498
DOI  :  10.1186/1477-5956-10-17

 received in 2011-08-17, accepted in 2012-03-15,  发布年份 2012

【 摘 要 】

Background

Proteins that are associated with hypertension may be identified by comparing the 2-dimensional gel electrophoresis (2-DE) profiles of the sera of spontaneously hypertensive rats (SHR) with those generated from normotensive Spraque-Dawley rats (SDR).

Results

Five proteins of high abundance were found to be significantly altered when the 2-DE serum profiles of the SHR were compared to those that were similarly generated from the SDR. Analysis by mass spectrometry and database search identified the proteins as retinol binding protein 4, complement C3, albumin (19.9 kDa fragment), alpha1 macroglobulin and alpha1 antiproteinase, which are all known to be associated with hypertension. The altered expression of the two latter proteins was found to be abrogated when similar analysis was performed on sera of the SHR that were treated with captopril.

Conclusion

Our data suggests that serum alpha1 macroglobulin and alpha1 antiproteinase are potentially useful complementary biomolecular indicators for monitoring of hypertension.

【 授权许可】

   
2012 Aminudin et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Okamoto AK, Aoki K: Development of a strain of spontaneously hypertensive rat. Jap Circ J 1963, 27:282-293.
• [2]Conrad CH, Brooks WW, Hayes JA, Sen S, Robinson KG, Bing OH: Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat. Circulation 1995, 91:161-170.
• [3]Cloix JF, Devynck MA, Brentano JL, Meyer P: Plasma protein changes in primary hypertension in humans and rats. Hypertension 1983, 5:128-134.
• [4]Engström G, Hedblad B, Janzon L, Lindgärde F: Fatality of acute coronary events in relation to hypertension and low-grade inflammation: a population-based cohort study. J Hum Hypertension 2006, 20:581-586.
• [5]Kiga C, Sakurai H, Goto H, Hayashi K, Shimada Y, Saiki I: Proteomic identification of haptoglobin as a stroke plasma biomarker in spontaneously hypertensive stroke-prone rats. Life Sci 2008, 83:625-631.
• [6]Lin ZH, Fukuda N, Jin XQ, Yao EH, Ueno T, Endo M, Saito S, Matsumoto K, Mugishima H: Complement 3 is involved in the synthetic phenotype and exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension 2004, 44:42-47.
• [7]Boos CJ, Lip GYH: Is Hypertension an Inflammatory Process? Curr Pharm Des 2006, 12:1623-1635.
• [8]Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995, 57:289-300.
• [9]Quadro L, Blaner WS, Salchow DJ, Vogel S, Piantedosi R, Gouras P, Freeman S, Cosma MP, Colantuoni V, Gottesman ME: Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein. EMBO J 1999, 18:4633-4644.
• [10]Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB: Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005, 436:356-362.
• [11]Takebayashi K, Suetsugu M, Wakabayashi S, Aso Y, Inukai T: Retinol binding protein-4 levels and clinical features of type 2 diabetes patients. J Clin Endocrinol Metab 2007, 92:2712-2719.
• [12]Inoue S, Takamoto N, Akahori Y, Masumoto A, Nakatsukasa H, Msuyama H, Hiramatsu Y: Elevated level of serum retinol-binding protein 4 in pregnancy-induced hypertension. J Obstet Gynaecol Res 2009, 35:293-300.
• [13]Solini A, Santini E, Madec S, Rossi C, Muscelli E: Retinol-binding protein-4 in women with untreated essential hypertension. Am J Hypertens 2009, 22:1001-1006.
• [14]Zhang J, Zhang Y, Li N, Liu Z, Xiong C, Ni X, Pu Y, Hui R, He J, Pu J: Potential diagnostic biomarkers in serum of idiopathic pulmonary arterial hypertension. Respir Med 2009, 103:1801-1816.
• [15]Høstmark AT, Tomten SE, Berg JE: Serum albumin and blood pressure: a population-based, cross-sectional study. J Hypertens 2005, 23:725-730.
• [16]Tremblay J, Thibault G, Gutkowska J, Boucher R, Genest J: Purification and partial characterization of a plasma inhibitor of tonin. Can J Biochem 1981, 59:256-261.
• [17]Ikeda M, Sasaguri M, Maruta H, Arakawa K: Formation of angiotensinogen II by tonin-inhibitor complex. Hypertension 1988, 11:63-70.
• [18]Ikeda M, Arakawa K: Kininogenase activity of tonin. Hypertension 1984, 6:222-228.
• [19]Gettins PG: Serpin structure, mechanism and function. Chem Rev 2002, 102:4751-4804.
• [20]Doustjalali SR, Yusof Y, Yip CH, Looi LM, Pillay B, Hashim OH: Aberrant expression of acute-phase reactant proteins in sera and breast lesions of patients with malignant and benign breast tumors. Electrophoresis 2004, 25:2392-2401.
• [21]Heukeshoven J, Dernick R: Improved silver staining procedure for fast staining in PhastSystem Development Unit. I. Staining of sodium dodecyl sulfate gels. Electrophoresis 1988, 9:28-32.
• [22]Yan JX, Wait R, Berkelman T, Harry RA, Westbrook JA, Wheeler CH, Dunn MJ: A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry. Electrophoresis 2000, 21:3666-3672.
• [23]Seriramalu R, Pang WW, Jayapalan JJ, Mohamed E, Abdul-Rahman PS, Bustam AZ, Khoo ASB, Hashim OH: Application of champedak mannose-binding lectin in the glycoproteomic profiling of serum samples unmasks reduced expression of alpha-2 macroglobulin and complement factor B in patients with nasopharyngeal carcinoma. Electrophoresis 2010, 31:2388-2395.